IMMUNOVEDA

Serial Number 88664944
602

Registration Progress

Application Filed
Oct 23, 2019
Under Examination
Apr 7, 2020
Approved for Publication
Feb 11, 2020
Published for Opposition
Feb 11, 2020
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: IMMUNOVEDA
Previous Owner: Genesis Drug, Discovery & Development, LLC
Classes: 044

Trademark Image

IMMUNOVEDA

Basic Information

Serial Number
88664944
Filing Date
October 23, 2019
Published for Opposition
February 11, 2020
Abandonment Date
August 10, 2023
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Aug 23, 2023
Classes
044

Rights Holder

Genesis Drug, Discovery & Development, LLC

16
Address
law department
2439 Kuser Road
Hamilton, NJ 08690

Ownership History

Genesis Drug, Discovery & Development, LLC

Original Applicant
16
Hamilton, NJ

Genesis Drug, Discovery & Development, LLC

Owner at Publication
16
Hamilton, NJ

Legal Representation

Attorney
Arnold Braun

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

38 events
Date Code Type Description Documents
Aug 23, 2023 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Aug 23, 2023 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Aug 23, 2023 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
May 9, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 9, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 9, 2023 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Apr 19, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Apr 4, 2023 IUAF S USE AMENDMENT FILED Loading...
Apr 4, 2023 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Sep 21, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 20, 2022 EX5G S SOU EXTENSION 5 GRANTED Loading...
Sep 14, 2022 EXT5 S SOU EXTENSION 5 FILED Loading...
Sep 14, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 13, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 12, 2022 EX4G S SOU EXTENSION 4 GRANTED Loading...
Apr 5, 2022 EXT4 S SOU EXTENSION 4 FILED Loading...
Apr 5, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 28, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 24, 2021 EX3G S SOU EXTENSION 3 GRANTED Loading...
Sep 24, 2021 EXT3 S SOU EXTENSION 3 FILED Loading...
Sep 24, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 20, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 19, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 1, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 1, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 15, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 14, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 9, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 14, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 9, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 7, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 11, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 11, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 22, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 8, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 8, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 29, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 26, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 044
Medical treatment of cancer; Medical diagnosis and treatment of cancer; Medical testing for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of cancer
First Use Anywhere: 20201100
First Use in Commerce: 20201100

Classification

International Classes
044